Compounding Bill In Senate Adds Office Use Provisions
This article was originally published in The Pink Sheet Daily
Executive Summary
New version of compounding bill would allow compounders to produce limited supplies for office use, but schedule for Senate floor action remains to be seen.
You may also be interested in...
Makena’s Orphan Exclusivity Is “Nullified” By FDA’s Compounding Policy, KV Suit Says
KV seeks a court order requiring FDA to desist from permitting importation of unapproved API for compounded hydroxyprogesterone and to state its intent to take enforcement action against compounders.
Postmarketing Trial For Horizon Thyroid Eye Drug Tepezza To Be Larger Than Expected
Horizon CEO says safety trial will be conducted in a larger patient population following discussions during the US FDA advisory committee meeting.
Complex Generic Approval Delays Getting Congressional Attention
US Energy and Commerce Committee leaders request data on complex generic approvals, guidances, saying additional changes may be needed for faster approvals.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: